Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Immersive goggles are moving from novelty to surgical staple, with early studies pointing to shorter operating times, reduced workloads, and better ergonomics. But experts caution that the evidence is still thin and non-randomized. The real sweet spot may be in training and remote expert access — not necessarily routine OR use.
Immersive goggles — think Apple Vision Pro in the operating room — are gaining traction across surgical specialties, but the evidence may not yet match the enthusiasm. Early studies in procedures like endoscopic dacryocystorhinostomy and cataract surgery suggest benefits including shorter operating times, lower surgeon-reported workloads, and improved neck posture. Still, the data are small, non-randomized, and not yet sufficient to support routine clinical use.
Spanish surgeon José María Balibrea del Castillo, who has been integrating the technology since 2023, urges a measured approach: adoption should be driven by specific clinical need and outcome evaluation — not device appeal. He also flags practical concerns like eye strain, weight distribution, and the risk of misinterpreting a frozen or delayed image as live during a procedure.
Key Takeaways:
Why it matters: As immersive tech edges into surgical suites, clinicians and hospital administrators need a clear-eyed framework for evaluating real-world value — because a promising device that introduces new intraoperative risks requires careful, evidence-based vetting before widespread adoption.